Violeta Serra Elizalde

Title: Violeta Serra Elizalde: Innovator in Cancer Treatment Methods

Introduction

Violeta Serra Elizalde is a prominent inventor based in Barcelona, Spain. She has made significant contributions to the field of oncology through her innovative methods for determining cancer treatment sensitivity. Her work is particularly focused on the detection of RAD51 foci in tumor cells, which has implications for personalized cancer therapy.

Latest Patents

Violeta holds a patent for her invention titled "Methods based on the detection of RAD51 foci in tumor cells." This method allows for the determination of whether a subject diagnosed with cancer is sensitive or resistant to anti-cancer treatments. The invention is based on analyzing the level of cells with RAD51 foci in tumor samples, ensuring that the subject has not received specific chemotherapy treatments within 24 hours prior to sample isolation. This innovative approach aims to enhance the effectiveness of cancer therapies by tailoring them to individual patient needs.

Career Highlights

Throughout her career, Violeta has worked with notable organizations, including the Fundació Privada Institut d'Investigació Oncològica de Vall Hebron and AstraZeneca U.K. Limited. Her experience in these institutions has allowed her to collaborate with leading experts in the field of cancer research and treatment.

Collaborations

Violeta has collaborated with esteemed colleagues such as Judith Balmaña Gelpi and Cristina Cruz Zambrano. These partnerships have contributed to her research and the advancement of cancer treatment methodologies.

Conclusion

Violeta Serra Elizalde is a trailblazer in the field of cancer research, with her innovative patent offering new hope for personalized cancer treatment. Her dedication to improving patient outcomes through scientific advancements is commendable.